Official School of Record
HCISR | ASCLE+ ATHENS EXPERIENCE
Valuing Medicines: Drug
Pricing & Healthcare
Decisions
Health Economics, Public Health Policy, Healthcare Decision Science
An interdisciplinary field-based course examining how health systems
determine the value of medicines through health economic evaluation,
pharmaceutical pricing and reimbursement, and healthcare decision-making,
drawing on real-world examples and field experiences in Greece.
Apply Now
Schedule a Call
Download Syllabus
Why This Course and Why Now?
Drug pricing and pharmaceutical reimbursement have become one of the defining public health challenges of our time. As health
systems across Europe and beyond face mounting pressure to allocate limited resources, the question of how to measure the value of
a medicine -- and who decides -- has never been more urgent.
Greece offers a uniquely compelling case study: a country that navigated a severe healthcare austerity crisis, restructured its
pharmaceutical reimbursement system, and continues to grapple with the tensions between innovation, access, and sustainability.
This course places students inside that story.
3
Credits
Undergraduate
academic credits via
Arcadia Abroad
27
Days On-Site
Full immersive program
in Athens, Greece (May
24 – June 19, 2027)
12
Academic
Sessions
Structured sessions
across 3 thematic
modules
4+
Field Visits
Aegina, Delphi,
Peloponnese & Athens
sites
3+
Guest Experts
Health policy
professionals
Learning Outcomes
Guided by expert faculty in health economics and pharmaceutical policy,
students develop analytical and applied skills through seminars, data
workshops, case studies, guest lectures, and field-based learning.
Analyze Pharmaceutical Value
Examine the economic frameworks used to assess whether a new
medicine provides sufficient value to justify its cost in a public health
system.
Understand Cost-Effectiveness
Apply cost-effectiveness analysis (CEA) frameworks to evaluate
pharmaceutical interventions against clinical outcomes and treatment
costs.
Interpret Health Data
Read and analyze epidemiological and healthcare expenditure datasets
to understand how quantitative evidence informs resource allocation
decisions.
Understand QALYs
Master the concept of Quality-Adjusted Life Years (QALYs) and their role
in health economic evaluation and cost-effectiveness analysis.
Evaluate Reimbursement Decisions
Assess the trade-offs involved in healthcare resource allocation using
both quantitative evidence and policy considerations.
Prepare Policy Briefs
Construct a concise, evidence-based policy brief recommending whether
a health system should reimburse a new pharmaceutical intervention.
Who Is This Course For?
No formal prerequisites are required. The course is open to undergraduate students from a range of academic backgrounds. Basic
familiarity with statistics, economics, or public health concepts may be helpful but is not required.
Public Health
Students seeking hands-on exposure to pharmaceutical policy, health system financing, and evidence-based resource
allocation in a real-world European context.
Health Economics
Students interested in applying economic frameworks -- CEA, QALYs, budget impact analysis -- to real pharmaceutical
and healthcare decision-making scenarios.
Pharmacy
Future pharmacists seeking to understand how drug pricing, reimbursement systems, and health technology
assessment shape access to medicines.
Pre-Med & Medicine
Medical students who want to understand the economic and policy dimensions of clinical decision-making and
pharmaceutical innovation.
Healthcare Management
Students preparing for careers in hospital administration, health insurance, or healthcare consulting -- where resource
allocation decisions are central.
Public Policy & Political Science
Students interested in how governments regulate pharmaceutical markets, negotiate drug prices, and balance innovation
with public health equity.
Global Health & International Affairs
Students exploring how international health systems compare in their approaches to pharmaceutical access, pricing, and
sustainability.
Curriculum: 3 Modules, 12 Sessions
The course moves from the foundations of health economic evaluation, through pharmaceutical pricing and cost-effectiveness
analysis, to applied healthcare policy and decision-making -- culminating in a Final Policy Brief.
Module 1
Health Economics Foundations
Sessions 1–4: Introduction to health economic evaluation,
healthcare resource allocation & decision-making, cost-
effectiveness analysis (CEA), QALYs and measuring health
outcomes.
Module 2
Drug Pricing & Economic Evaluation
Sessions 5–9: Epidemiological data & healthcare
expenditure, guest lecture on prevention & public health,
pharmaceutical pricing models, budget impact analysis,
evaluating a pharmaceutical intervention.
Module 3
Healthcare Policy & Decision Making
Sessions 10–12: Health policy and reimbursement
decisions, policy brief development workshop, healthcare
trade-offs & resource allocation -- culminating in Final
Policy Brief presentations.
Assignments
Assessment is designed to build progressively -- from active seminar engagement and analytical exercises to applied case study work
and a final policy brief.
1
Class Participation & Seminar Discussion --
15%
Students are expected to actively participate in seminar discussions based on assigned readings and case materials.
Participation includes contributing to guided discussions on pharmaceutical pricing, healthcare resource allocation, and
policy trade-offs in drug reimbursement decisions.
2
Data Interpretation Exercises --
25%
Short analytical exercises interpreting epidemiological and healthcare expenditure datasets. Focused on developing
skills in reading quantitative evidence used in health economic evaluation and understanding how such evidence informs
resource allocation and reimbursement decisions.
3
Economic Evaluation Case Study --
25%
Analysis of a structured case involving the economic evaluation of a pharmaceutical intervention. Using simplified cost-
effectiveness frameworks, students interpret clinical outcomes, treatment costs, and estimated health benefits to assess
the value of a medical technology.
4
Final Policy Brief --
35%
A short policy brief recommending whether a healthcare system should reimburse a new pharmaceutical intervention.
Students synthesize clinical evidence, economic evaluation results, and policy considerations to defend a resource
allocation recommendation.
Program Experience
A multi-format learning environment combining academic seminars, applied data workshops, guest lectures from health policy
professionals, and structured field-based activities across Athens and Greece.
Faculty-Led Seminars
4 weeks of structured academic
sessions covering health economic
evaluation, pharmaceutical pricing,
cost-effectiveness analysis (CEA),
QALYs, and healthcare policy decision-
making.
Applied Data Workshops
Hands-on interpretation of
epidemiological and healthcare
expenditure datasets -- developing
skills in reading quantitative evidence
used in health economic evaluation
and reimbursement decisions.
Guest Lecture: Prevention &
Public Health
Expert guest lecture connecting public
health concepts with pharmaceutical
pricing and health system decision-
making.
Day Excursion to Aegina --
Mediterranean Diet
Workshop
Academic day excursion to Aegina
including a Mediterranean diet
workshop, connecting lifestyle,
prevention, and health economics
within the broader academic
experience in Greece.
Three-Day Academic
Excursion
Three-day academic excursion
examining health and medicine --
visiting sites such as Nafplio,
Epidaurus, or Delphi.
Site Visit: Pharmaceutical or
Health Policy Organization
Students take part in a structured
policy debate on healthcare resource
allocation, examining the challenges
involved in allocating limited
healthcare resources. The course also
includes a supervised site visit to a
pharmaceutical or health policy
organization, giving students the
opportunity to engage with a real-
world institutional setting.
Policy Brief Presentations
Final presentations of student Policy
Briefs -- recommending whether a
healthcare system should reimburse a
new pharmaceutical intervention,
synthesizing clinical evidence,
economic evaluation, and policy
considerations.
Meet the Faculty
Learn from an expert practitioner in data analytics and health economics, embedded in the Greek academic and research landscape.
Theoktisti Ntoumani, MSc
Data Analyst & Health Economics - Faculty -- HCISR
Theoktisti Ntoumani is a data analytics professional with over a decade of experience in European, international, and
national projects across both the private and nonprofit sectors. She specializes in advanced data-driven
methodologies, predictive modeling, and computational approaches.
MSc in Data Analytics; extensive experience in EU, ESA, EDIDP, IOM, UNHCR, and UNICEF-funded projects
Technical expertise in machine learning, algorithmic modeling, artificial intelligence techniques, and advanced
analytical frameworks for large-scale data processing
Active participant in educational programs related to biostatistics, statistical analysis, and mathematical
modeling -- including workshops hosted by the Greek Statistical Institute and the Hungarian Centre of Excellence
for Molecular Medicine
Key role at HCISR in developing and advancing interdisciplinary STEM initiatives, supporting team coordination
and programmatic coherence
Expertise in computational bioinformatics, data analysis, and modeling applications relevant to health economics
and pharmaceutical evaluation
Course Details
Course Code:
HCISR_ECONPUBH 340_01012026
Course Title:
Valuing Medicines: Drug Pricing and Healthcare
Decisions
Subject:
Health Economics, Public Health Policy, Healthcare
Decision Science
Credits:
3 undergraduate credits
Contact Hours:
40
Term:
Summer 2027
Dates:
May 24 – June 19, 2027
Location:
Athens, Greece (with field excursions to Aegina, Nafplio,
Epidaurus, or Delphi)
Format:
On-site, field-based
School of Record:
Arcadia Abroad (Arcadia University | The
College of Global Studies)
On-site Provider:
HCISR
This course does not grant academic credit directly from
HCISR. Credits are awarded through Arcadia Abroad as the
official School of Record.
Contact & Apply
Website:
www.hcisr.com
This program is offered in partnership with
Arcadia Abroad
, the official
School of Record, to support undergraduate students studying abroad
in Athens.
Apply Now
Schedule a Call
HCISR | ASCLE+ ATHENS EXPERIENCE -- SUMMER 2027
Ready to Study Health Economics in Greece?
Join a cohort of American undergraduate students examining pharmaceutical pricing, healthcare decision-making, and public health
policy -- in one of the world's most compelling academic settings.
Download Syllabus
Learn About Arcadia Abroad